NVNO Short Volume

enVVeno Medical Corporation (NVNO) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $181,368, listed on NASDAQ, employing roughly 33 people, carrying a beta of 1.09 to the broader market. enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. Led by Robert A. Berman, public since 2018-05-31.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-14
Short Volume
73
Total Volume
675
Short %
10.81%
30-Day Avg Short %
46.55%

Showing 30 days of FINRA short volume data for enVVeno Medical Corporation.

Learn how short volume is reported and how to read the data →

Frequently asked NVNO short volume questions

What is the daily NVNO short volume?
As of Aug 14, 2026, enVVeno Medical Corporation (NVNO) short volume is 73 shares against 675 total reported volume, or 10.81% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is NVNO short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does NVNO short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.